GO:0004802 transketolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• Transketolase activity (GO:0004802) catalyzes the reversible transfer of a 2-carbon ketol group from a ketose phosphate donor to an aldose phosphate acceptor, a central reaction of the non-oxidative pentose phosphate pathway [1,5].
• The reaction requires thiamine pyrophosphate (TPP) as an essential cofactor, and its activity is widely used as a biomarker of thiamine status in humans [2,3].
• Transketolase is encoded by the TKT gene in humans, and its activity supports nucleotide synthesis, NADPH production, and maintenance of redox balance [1,8].
• Dysregulated transketolase activity contributes to metabolic dysfunction-associated fatty liver disease (MAFLD) and hepatocellular carcinoma progression [1,8].
• Transketolase activity can be measured in erythrocytes, tissues, and cell lysates using coupled enzymatic assays, with protocols standardized for clinical and research use [2,7].
• Small-molecule inhibitors of transketolase are being developed and evaluated for binding affinity and metabolic regulatory activity, offering new therapeutic avenues.
Description
Transketolase activity (GO:0004802) is a molecular function defined as the catalysis of the reversible transfer of a 2-carbon ketol group (CH2OH-CO-) from a ketose phosphate donor to an aldose phosphate acceptor [1,5]. This reaction is a cornerstone of the non-oxidative branch of the pentose phosphate pathway, linking glycolytic intermediates to ribose-5-phosphate for nucleotide biosynthesis and to erythrose-4-phosphate for aromatic amino acid synthesis [1,8]. In humans, transketolase is encoded by the TKT gene, and its activity is thiamine pyrophosphate (TPP)-dependent, making it a sensitive indicator of thiamine (vitamin B1) status [2,3]. Researchers study transketolase activity to understand metabolic reprogramming in cancer, metabolic liver disease, and neurological disorders, as well as to assess nutritional thiamine deficiency [1,6,8]. The enzyme's ability to modulate flux between glycolysis and the pentose phosphate pathway positions it as a critical node in cellular metabolism [1,8].
transketolase activity At A Glance
| GO ID | GO:0004802 |
|---|---|
| GO term | transketolase activity |
| Ontology | molecular_function |
| Synonym | fructose 6-phosphate:D-glyceraldehyde-3-phosphate glycolaldehydetransferase activity; glycoaldehyde transferase activity; glycolaldehydetransferase activity; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glycolaldehydetransferase activity |
| Major function | Reversible transfer of a 2-carbon ketol group from a ketose phosphate donor to an aldose phosphate acceptor |
| Cofactor | Thiamine pyrophosphate (TPP) |
| Pathway | Non-oxidative pentose phosphate pathway |
| Human gene | TKT |
| Substrate inhibition | Yes, at high substrate concentrations |
What Is GO:0004802?
Transketolase activity (GO:0004802) is the catalytic function of an enzyme that transfers a 2-carbon ketol group from a ketose phosphate donor, such as xylulose-5-phosphate or sedoheptulose-7-phosphate, to an aldose phosphate acceptor, such as ribose-5-phosphate or glyceraldehyde-3-phosphate [1,5]. This reversible reaction is essential for carbon shuffling in the non-oxidative pentose phosphate pathway, enabling the interconversion of sugars to meet cellular demands for ribose-5-phosphate and NADPH [1,8]. The activity strictly requires thiamine pyrophosphate (TPP) as a cofactor and is inhibited by excess substrate.
Why Is transketolase activity Important in Cell Biology?
Transketolase activity is critical for maintaining metabolic flexibility, as it connects glycolysis with the pentose phosphate pathway to supply ribose-5-phosphate for nucleotide synthesis and NADPH for reductive biosynthesis and antioxidant defense [1,8]. Its TPP dependence makes it a functional biomarker for thiamine deficiency, which can lead to neurological and cardiovascular disorders [2,3]. In cancer, elevated transketolase activity supports tumor growth by enhancing nucleic acid synthesis and redox balance, and its inhibition is being explored as a therapeutic strategy [4,8]. In metabolic diseases such as MAFLD, transketolase activity modulates mitochondrial function and lipid accumulation, highlighting its broader physiological relevance.
• Provides ribose-5-phosphate for nucleotide biosynthesis, supporting cell proliferation [1,8].
• Generates NADPH to maintain redox homeostasis and support reductive biosynthesis.
• Serves as a functional marker of thiamine (vitamin B1) status in clinical settings [2,3].
• Contributes to metabolic reprogramming in hepatocellular carcinoma, promoting tumor growth.
• Modulates mitochondrial activity and lipid metabolism in MAFLD.
• Is a target for small-molecule inhibitors with potential anticancer activity.
• Exhibits substrate inhibition, a regulatory feature that may prevent metabolic imbalance.
• Its activity changes in response to hyperglycaemia and kidney dysfunction, linking it to diabetic complications.
• Can be measured in erythrocytes, providing a minimally invasive window into systemic thiamine status [2,3].
• Plays a role in the pentose phosphate pathway's adaptation to oxidative stress.
What Happens During transketolase activity?
Substrate Binding and Ketol Transfer
In simple terms: The enzyme grabs a sugar phosphate and moves a two-carbon piece to another sugar.
Transketolase binds a ketose phosphate donor, such as xylulose-5-phosphate, and an aldose phosphate acceptor, such as ribose-5-phosphate [1,5]. The enzyme's TPP cofactor facilitates the cleavage of the ketol group from the donor, which is then transferred to the acceptor, forming a new ketose phosphate and an aldose phosphate. This reversible reaction is central to the non-oxidative pentose phosphate pathway [1,8].
Cofactor Role of Thiamine Pyrophosphate
In simple terms: Vitamin B1 derivative acts as a handle to carry the two-carbon unit.
Thiamine pyrophosphate (TPP) is essential for transketolase activity; it covalently binds the ketol group during catalysis [2,3]. The TPP-dependent mechanism is conserved across species, and mutations affecting TPP binding reduce or abolish activity. This cofactor requirement underlies the use of transketolase activity as a biomarker for thiamine deficiency [2,3].
Substrate Inhibition and Regulation
In simple terms: Too much substrate can slow the enzyme down.
Transketolase exhibits substrate inhibition, where high concentrations of the donor or acceptor substrate reduce catalytic efficiency. This regulatory feature may prevent excessive flux through the pathway and maintain metabolic balance. The enzyme's activity is also influenced by thiamine availability and post-translational modifications [2,6].
Integration with Glycolysis and Redox Balance
In simple terms: The enzyme connects sugar breakdown with the production of building blocks and antioxidants.
By interconverting sugars, transketolase activity links glycolysis to the pentose phosphate pathway, supplying ribose-5-phosphate for nucleotides and NADPH for redox defense [1,8]. In cancer cells, this integration supports proliferation and survival under oxidative stress. In metabolic tissues, it modulates mitochondrial activity and lipid handling.
Key Genes Involved in GO:0004802 transketolase activity
The following genes and proteins are directly involved in transketolase activity or its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TKT | Encodes transketolase, the enzyme catalyzing the reaction | Central to pentose phosphate pathway; target in cancer and metabolic disease [1,8] |
| TKT (nuclear localization) | Non-metabolic role in promoting hepatocellular carcinoma | Nuclear TKT promotes tumor growth independent of metabolic activity |
| TPP-binding domains | Cofactor binding and catalysis | Mutations affect thiamine responsiveness and activity [2,3] |
| GAPDH | Glycolytic enzyme providing glyceraldehyde-3-phosphate acceptor | Links glycolysis to transketolase reaction |
| RPE | Ribulose-5-phosphate epimerase, generates xylulose-5-phosphate | Supplies substrate for transketolase |
| RPIA | Ribose-5-phosphate isomerase, generates ribose-5-phosphate | Provides acceptor substrate |
| TALDO1 | Transaldolase, works with transketolase in pentose phosphate pathway | Metabolic cooperation |
| G6PD | Glucose-6-phosphate dehydrogenase, oxidative branch | Provides NADPH and links to transketolase flux |
| PKM2 | Pyruvate kinase M2, regulates glycolytic flux | Modulates substrate availability |
| HIF1A | Hypoxia-inducible factor, regulates metabolic genes | May influence transketolase expression |
| MYC | Oncogene driving metabolic reprogramming | Associated with increased transketolase activity |
| TP53 | Tumor suppressor, regulates metabolism | Loss may alter pentose phosphate pathway flux |
| INS | Insulin, regulates glucose metabolism | Hyperglycaemia affects transketolase activity |
| SLC19A2 | Thiamine transporter | Thiamine uptake influences TPP availability |
| SLC19A3 | Thiamine transporter | Thiamine uptake influences TPP availability |
| SLC25A19 | Mitochondrial thiamine pyrophosphate carrier | TPP transport for cofactor supply |
| TKT (inhibitor target) | Binding affinity for small-molecule inhibitors | Therapeutic development |
How Is transketolase activity Regulated?
Transketolase activity is regulated at multiple levels. Its dependence on thiamine pyrophosphate (TPP) means that cellular thiamine availability directly controls catalytic capacity [2,3]. Substrate inhibition provides a feedback mechanism to prevent excessive flux. In cancer, transketolase expression and activity can be upregulated by oncogenic signals such as MYC and HIF1A, supporting metabolic reprogramming. In metabolic diseases, hyperglycaemia and kidney dysfunction alter transketolase activity, suggesting hormonal and metabolic regulation. Additionally, nuclear localization of TKT confers a non-metabolic function in hepatocellular carcinoma, indicating that subcellular compartmentalization regulates its role.
transketolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TKT | Hepatocellular carcinoma | TKT knockout or overexpression in liver cancer cell lines |
| TKT | MAFLD | Liver-specific TKT knockout mice |
| TKT | Thiamine deficiency | Erythrocyte transketolase activity assay in patient samples [2,3] |
| TKT | Hyperglycaemia and kidney dysfunction | Cell models under high glucose |
| TKT | Cancer metabolism | TKT inhibitor treatment in cancer cells |
Transketolase activity in Hepatocellular Carcinoma
Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in both metabolic and non-metabolic manners. Elevated TKT supports nucleotide synthesis and redox balance, fueling tumor growth. Targeting TKT activity or its nuclear function may offer therapeutic benefits.
Transketolase activity in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity. This suggests that transketolase activity modulates mitochondrial function and lipid metabolism, contributing to disease progression. Inhibiting transketolase may restore mitochondrial activity and alleviate MAFLD.
Transketolase activity as a Biomarker of Thiamine Deficiency
Erythrocyte transketolase activity coefficient (ETKAC) is a functional assay for thiamine status. Reduced transketolase activity indicates thiamine deficiency, which can cause neurological and cardiovascular disorders [2,3]. This assay is used clinically to assess thiamine balance.
Transketolase activity in Hyperglycaemia and Kidney Dysfunction
Transketolase activity changes in response to hyperglycaemia and kidney dysfunction, but not due to altered thiamine membrane transport. This links transketolase to diabetic complications and renal disease.
From transketolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TKT loss affect tumor growth? | TKT knockout cancer cell lines and xenografts |
| Does TKT overexpression promote MAFLD? | Liver-specific TKT overexpression in mice |
| Does a point mutation in TPP-binding domain alter activity? | CRISPR knock-in of point mutations in TKT |
| Does nuclear TKT have a non-metabolic role? | TKT knockout with nuclear localization signal mutant |
| Can transketolase inhibitors reduce activity? | In vitro enzymatic assays with inhibitors |
| Does thiamine status affect transketolase activity? | Erythrocyte assay in thiamine-deficient models [2,3] |
How to Study the transketolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ETKAC assay | Erythrocyte transketolase activity coefficient | Thiamine status assessment |
| Coupled spectrophotometric assay | Transketolase activity via NADH oxidation | Enzyme kinetics and inhibitor testing |
| Substrate inhibition assay | Activity at varying substrate concentrations | Regulatory studies |
| Inhibitor binding assay | Binding affinity of small molecules | Drug discovery |
| Metabolomics | Pentose phosphate pathway intermediates | Metabolic flux analysis |
| Isotope tracing | Carbon flux through transketolase | Cancer metabolism |
| Western blot | TKT protein expression | Correlation with activity |
| Immunofluorescence | Subcellular localization of TKT | Nuclear function studies |
Enzymatic Activity Assays
Transketolase activity is measured spectrophotometrically by coupling the formation of glyceraldehyde-3-phosphate to NADH oxidation via glycerol-3-phosphate dehydrogenase. Erythrocyte transketolase activity coefficient (ETKAC) is a standardized protocol for assessing thiamine status. These assays are used in clinical and research settings.
Substrate Inhibition and Kinetic Studies
Kinetic analyses reveal substrate inhibition, where high substrate concentrations reduce activity. Such studies help understand regulatory mechanisms and design inhibitors.
Inhibitor Binding and Affinity Evaluation
Small-molecule inhibitors of transketolase are evaluated for binding affinity and metabolic regulatory activity using biochemical and cellular assays. These methods are essential for drug development.
Metabolic Flux Analysis
Isotope tracing and metabolomics can quantify flux through the pentose phosphate pathway, revealing transketolase's contribution to ribose-5-phosphate and NADPH production [1,8]. This is particularly relevant in cancer and metabolic disease research [1,8].
How CRISPR Can Be Used to Study GO:0004802 transketolase activity
Knockout
CRISPR knockout of TKT eliminates transketolase activity, allowing researchers to study its role in metabolic pathways, cancer growth, and MAFLD [1,8]. Knockout cell lines can be used to assess sensitivity to oxidative stress and nucleotide synthesis inhibitors.
Point Mutation
Point mutations in the TPP-binding domain of TKT can be introduced via CRISPR to dissect cofactor binding and catalytic mechanism. Such models help determine how specific residues affect transketolase activity and thiamine responsiveness.
Knock-in
Knock-in of tagged TKT (e.g., GFP or FLAG) enables visualization and immunoprecipitation of the enzyme, facilitating studies of its subcellular localization and interaction partners. This is particularly useful for investigating nuclear TKT functions.
Overexpression
CRISPR activation or lentiviral overexpression of TKT increases transketolase activity, modeling the metabolic reprogramming seen in cancer and MAFLD [1,8]. Overexpression models can be used to test inhibitors and assess metabolic flux.
How EDITGENE Supports transketolase activity Research
Researchers studying transketolase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or thiamine-dependent processes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of transketolase and its regulators.
Contact EDITGENE today to design your custom CRISPR model for transketolase activity research.
Frequently Asked Questions About transketolase activity
What is transketolase activity?
Transketolase activity (GO:0004802) is the catalysis of the reversible transfer of a 2-carbon ketol group from a ketose phosphate donor to an aldose phosphate acceptor, a key reaction in the pentose phosphate pathway [1,5].
What genes are involved in transketolase activity?
The primary gene is TKT, which encodes the transketolase enzyme. Other genes such as RPE, RPIA, and TALDO1 support the pathway [1,8].
What is the role of thiamine in transketolase activity?
Thiamine pyrophosphate (TPP), a derivative of vitamin B1, is an essential cofactor for transketolase activity [2,3].
How is transketolase activity measured?
It is measured using coupled enzymatic assays in erythrocytes or tissues, such as the ETKAC assay for thiamine status [2,7].
What diseases are associated with transketolase activity?
Altered transketolase activity is linked to hepatocellular carcinoma, MAFLD, thiamine deficiency, and diabetic complications [1,6,8].
Can transketolase activity be inhibited?
Yes, small-molecule inhibitors of transketolase have been developed and evaluated for binding affinity and metabolic effects.
What is substrate inhibition of transketolase?
Substrate inhibition occurs when high concentrations of substrates reduce transketolase activity, a regulatory mechanism.
Does transketolase have non-metabolic functions?
Yes, nuclear localization of TKT promotes hepatocellular carcinoma independent of its metabolic activity.
How does hyperglycaemia affect transketolase activity?
Hyperglycaemia and kidney dysfunction can change transketolase activity, but not via thiamine membrane transport.
What CRISPR models are available for transketolase research?
Knockout, point mutation, knock-in, and overexpression models can be generated to study TKT function and regulation [1,8].
Conclusion
Transketolase activity (GO:0004802) is a fundamental molecular function that bridges glycolysis and the pentose phosphate pathway, with critical roles in nucleotide synthesis, redox balance, and metabolic regulation [1,8]. Its TPP dependence makes it a key biomarker for thiamine status, and its dysregulation is implicated in cancer and metabolic diseases [2,3,8]. Advances in CRISPR-based models and enzymatic assays continue to illuminate its mechanistic and therapeutic potential [4,5]. Understanding transketolase activity offers insights into cellular metabolism and disease pathogenesis, paving the way for targeted interventions.
References
- 1. Tong L et al.. 2024. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity.. Cell Metab 36(5):1013-1029.e5 PMID: 38547864
- 2. Jones KS et al.. 2021. Erythrocyte transketolase activity coefficient (ETKAC) assay protocol for the assessment of thiamine status.. Ann N Y Acad Sci 1498(1):77-84 PMID: 33354793
- 3. Boston LY. 1975. [The transketolase activity in erythrocytes as a criterion for thiamine balance in the body].. Vopr Med Khim 21(4):339-43 PMID: 766392
- 4. Jia D et al.. 2025. Evaluation of binding, affinity and metabolic regulatory activity of a transketolase inhibitor.. Methods Enzymol 722:51-72 PMID: 41203359
- 5. Solovjeva ON et al.. 2016. Substrate inhibition of transketolase.. Biochim Biophys Acta 1864(3):280-282 PMID: 26708478
- 6. Chalásová K et al.. 2018. Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction.. Exp Clin Endocrinol Diabetes 126(4):255-262 PMID: 28950391
- 7. Sevostyanova IA et al.. 2006. Two methods for determination of transketolase activity.. Biochemistry (Mosc) 71(5):560-2 PMID: 16732737
- 8. Qin Z et al.. 2019. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.. J Exp Clin Cancer Res 38(1):154 PMID: 30971297
